LAB FY 2009 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2009 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$25M+65.6% YoY

Gross Profit

$14M54.8% margin

Operating Income

-$18M-71.0% margin

Net Income

-$19M-75.3% margin

EPS (Diluted)

$-11.02

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$32M

Total Liabilities

$206M

Stockholders' Equity

-$174M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$15M	+65.6%
Gross Profit	$14M	$7M	+99.4%
Operating Income	-$18M	-$30M	+38.9%
Net Income	-$19M	-$29M	+35.2%